World-wide trends in patterns of care for breast, cervical and ovarian cancers – The VENUSCANCER project
We will discuss the world-wide adherence to international clinical guidelines for cervical and ovarian cancer.
This event is hosted by the LSHTM Cancer Survival Group and is part of the London Global Cancer Week 2024.
The CONCORD programme documented wide global differences in survival trends, still persistent in 2010-2014, for women diagnosed with breast cancer (66% in India; over 90% in the US and Australia), cervical (52% in Ecuador; 77% in Korea) or ovarian (16% in India; 57% in Costa Rica) cancers.
The VENUSCANCER project, embedded in the CONCORD programme, examines whether global differences in survival are attributable to differences in disease biology between populations, or patterns of care, or socio-economic status.
Cancer registries were invited to submit data for a single year of complete incidence during 2015-2018, for which availability and completeness of high-resolution variables (e.g., stage, staging procedures, biomarkers, treatment) were highest. VENUSCANCER offered financial support to 11 registries in low- and middle-income countries to enable collection of these data.
During this webinar we will discuss the world-wide adherence to international clinical guidelines for cervical and ovarian cancer.
We are hosting a Zoom webinar anticipated to have over 100 participants. The session will focus on topics of interest to clinical professionals, researchers, and staff from cancer registries. Join us for an engaging discussion that promises to foster valuable insights and collaboration among experts in the field.
Speakers
Claudia Allemani, Professor in Global Public Health, LSHTM
Veronica Di Carlo, Research Fellow in Epidemiology, LSHTM
Clara Mackay, CEO World Ovarian Cancer Coalition, World Ovarian Cancer Coalition – From Evidence to Action
Event notices
- Please note this event is virtual only.
- Please note that the recording link will be listed on this page when available.
Admission
Contact
